Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections
- PMID: 22252808
- PMCID: PMC3318388
- DOI: 10.1128/AAC.05918-11
Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections
Abstract
Understanding factors associated with de novo daptomycin-nonsusceptible Enterococcus (DNSE) infections will aid in better understanding the mechanisms of daptomycin nonsusceptibility. We conducted a case-control study to compare patients with DNSE infections who were daptomycin treatment naïve (n = 9) and those with DNSE infections who had exposure to daptomycin (n = 13). Less frequent exposure to antimicrobials, increased susceptibility to nitrofurantoin and gentamicin, and shorter duration of hospitalization were associated with de novo DNSE infection, suggesting a potential community reservoir.
References
-
- Ballard SA, Grabsch EA, Johnson PD, Grayson ML. 2005. Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob. Agents Chemother. 49:77–81 - PMC - PubMed
-
- Clinical and Laboratory Standards Institute 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 8th ed Clinical and Laboratory Standards Institute, Wayne, PA
-
- Clinical and Laboratory Standards Institute 2011. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA
-
- Clinical and Laboratory Standards Institute 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
